NCT05453448View on ClinicalTrials.gov

The Renal Safety of Tenofovir Alafenamide in HBV-related Acute-on-chronic Liver Failure: Real-World Study

NACompletedINTERVENTIONAL

Enrollment

272

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

May 30, 2022

Study Completion Date

May 30, 2022

Conditions

Antiviral Drugs

Interventions

DRUG

tenofovir alafenamide

Antiviral therapy

DRUG

Entecavir

entecavir

Trial Locations (1)

Unknown

Wenting Peng, Changsha

All Listed Sponsors

lead

Xiangya Hospital of Central South University

OTHER